Aberrant expression of LGALS3 has been described in a variety of cancers, such as glioblastoma, colorectal cancer, hepatocellular carcinoma, thyroid carcinoma, and pancreatic ductal adenocarcinoma (PDAC) [18]. This evidence concerns the gene LGALS3 and colorectal cancer.